Substance PPeptide Chain Initiation, TranslationalSubstance-Related DisordersEukaryotic Initiation Factor-2Substance Abuse Treatment CentersReceptors, Neurokinin-1Base SequenceEukaryotic Initiation Factor-3Molecular Sequence DataProtein BiosynthesisEukaryotic Initiation FactorsTranscription, GeneticCodon, InitiatorProkaryotic Initiation Factor-2Thiobarbituric Acid Reactive SubstancesRNA, MessengerDNA ReplicationRibosomesProkaryotic Initiation Factor-3Humic SubstancesEukaryotic Initiation Factor-4AEukaryotic Initiation Factor-1Time FactorsHazardous SubstancesTranscription Initiation SiteDiagnosis, Dual (Psychiatry)Promoter Regions, GeneticTachykininsStreet DrugsEscherichia coliAmino Acid SequenceMutationNeurokinin-1 Receptor AntagonistsMarijuana AbuseRNA, Transfer, MetEukaryotic Initiation Factor-2BEukaryotic Initiation Factor-5Transcription Initiation, GeneticNeurokinin AKineticsSubstance Abuse DetectionReplication OriginPlasmidsRNA, ViralAdolescent BehaviorDNA-Binding ProteinsAlcoholismCell LineNucleic Acid ConformationCloning, MolecularReticulocytes5' Untranslated RegionsTranscription FactorsUnited StatesPerformance-Enhancing SubstancesDNA-Directed RNA PolymerasesBinding SitesProtein BindingRabbitsDNABacterial ProteinsHeLa CellsSaccharomyces cerevisiaeDrug and Narcotic ControlCells, CulturedMarijuana SmokingResidential TreatmentTemplates, GeneticDose-Response Relationship, DrugCodonGene Expression RegulationMental DisordersSignal TransductionHIV InfectionsCell-Free SystemModels, BiologicalAlcohol DrinkingRisk-TakingRNA Polymerase IIRisk FactorsPhosphorylationLongitudinal StudiesPolyribosomesPeer GroupControlled SubstancesTreatment OutcomePhysalaeminProkaryotic Initiation FactorsComorbidityGenesSmokingRestriction MappingViral ProteinsOpioid-Related DisordersReceptors, Neurokinin-2Cocaine-Related DisordersUnited States Substance Abuse and Mental Health Services AdministrationDNA, ViralReceptors, TachykininEledoisin